I

Isosceles Pharmaceuticals

9 employees

Isosceles Pharmaceuticals is a preclinical stage biotech company that is working on perioperative acute pain product candidates.

Basic info

pharmaceutical manufacturing

Biotechnology

Pain Therapy

Non NSAID

FDA

Global Health

Opioid Crisis

Biotech

Unmet Need

Acute Pain

Clinical Development

Intravenous

Medicine

Addiction Medicine

Non-Opioid

Small Molecule

Analgesia

Postoperative Pain

Transdermal

Inflammatory Disease

2019

$5M

from 1 investors over 1 rounds

I

Isosceles Pharmaceuticals raised $5M on October 3, 2022

Investors: Equifund